178 related articles for article (PubMed ID: 38263002)
1. Mitigation of intrahepatic cholestasis induced by 17α-ethinylestradiol via nanoformulation of Silybum marianum L.
Salem MB; Mohammed DM; Hammam OA; Elzallat M
BMC Complement Med Ther; 2024 Jan; 24(1):51. PubMed ID: 38263002
[TBL] [Abstract][Full Text] [Related]
2. Protective impact of lycopene on ethinylestradiol-induced cholestasis in rats.
Wadie W; Mohamed AH; Masoud MA; Rizk HA; Sayed HM
Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):447-455. PubMed ID: 33034714
[TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective potential of standardized Ficus species in intrahepatic cholestasis rat model: Involvement of nuclear factor-κB, and Farnesoid X receptor signaling pathways.
El-Hawary SS; Ali ZY; Younis IY
J Ethnopharmacol; 2019 Mar; 231():262-274. PubMed ID: 30458280
[TBL] [Abstract][Full Text] [Related]
4. Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells.
Alaca N; Özbeyli D; Uslu S; Şahin HH; Yiğittürk G; Kurtel H; Öktem G; Çağlayan Yeğen B
Turk J Gastroenterol; 2017 Nov; 28(6):476-484. PubMed ID: 29086715
[TBL] [Abstract][Full Text] [Related]
5. Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis.
Ming J; Xu Q; Gao L; Deng Y; Yin J; Zhou Q; Tong Q; Zhang Y
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34064649
[TBL] [Abstract][Full Text] [Related]
6. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic effect of resveratrol against ethinylestradiol-induced liver cholestasis.
Hussein MA
J Med Food; 2013 Mar; 16(3):246-54. PubMed ID: 23305807
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice.
Hua W; Zhang S; Lu Q; Sun Y; Tan S; Chen F; Tang L
J Ethnopharmacol; 2021 Feb; 266():113432. PubMed ID: 33011367
[TBL] [Abstract][Full Text] [Related]
9. Protective Effects of Ginsenosides on 17[Formula: see text]-Ethynyelstradiol-Induced Intrahepatic Cholestasis via Anti-Oxidative and Anti-Inflammatory Mechanisms in Rats.
Xu YJ; Yu ZQ; Zhang CL; Li XP; Feng CY; Lei K; He WX; Liu D
Am J Chin Med; 2017; 45(8):1613-1629. PubMed ID: 29121800
[TBL] [Abstract][Full Text] [Related]
10. [Effects of ursodeoxycholic acid on the liver plasma membrane fluidity, hepatic glutathione concentration, hepatic estrogen receptors and progesterone receptors in pregnant rats with ethinylestradiol and progesterone induced intrahepatic cholestasis].
Shi QY; Kong BH; Ma KD; Zhang XL; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):680-2. PubMed ID: 14728856
[TBL] [Abstract][Full Text] [Related]
11. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
Azer SA; Canfield PJ; Stacey NH
J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
[TBL] [Abstract][Full Text] [Related]
14. Intestinal injury in the rat model of 17α-ethynylestradiol-induced intrahepatic cholestasis.
Chang MJ; Xu YJ; He WX; Zhang CL; Li XP; Liu D
J Dig Dis; 2016 Nov; 17(11):756-763. PubMed ID: 27624611
[TBL] [Abstract][Full Text] [Related]
15. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q 10 supplementation: A potential therapeutic option for the treatment of intrahepatic cholestasis of pregnancy.
Martinefski MR; Rodriguez MR; Buontempo F; Lucangioli SE; Bianciotti LG; Tripodi VP
Eur J Pharmacol; 2020 Sep; 882():173270. PubMed ID: 32534074
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol modulates the gut microbiota of cholestasis in pregnant rats.
Li Z; Lei L; Ling L; Liu Y; Xiong Z; Shao Y
J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193965
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg1 alleviates ANIT-induced intrahepatic cholestasis in rats via activating farnesoid X receptor and regulating transporters and metabolic enzymes.
Xiao Q; Zhang S; Ren H; Du R; Li J; Zhao J; Gao Y; Zhu Y; Huang W
Chem Biol Interact; 2020 Jun; 324():109062. PubMed ID: 32198087
[TBL] [Abstract][Full Text] [Related]
19. [Study on protective effect of Chaihu Shugan Powder against liver injury in rats with intrahepatic cholestasis by regulating FXR/Nrf2/ARE pathway].
Lou J; Zhao L; Zhu YJ; Yuan SQ; Wang F; Zhang HZ; Xu JJ; Yu XK; Hou LF
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5610-5616. PubMed ID: 36471979
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.
Muchova L; Vanova K; Suk J; Micuda S; Dolezelova E; Fuksa L; Cerny D; Farghali H; Zelenkova M; Lenicek M; Wong RJ; Vreman HJ; Vitek L
J Cell Mol Med; 2015 May; 19(5):924-33. PubMed ID: 25683492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
